Upregulation of Tissue Factor by Activated Stat3 Contributes to Malignant Pleural Effusion Generation via Enhancing Tumor Metastasis and Vascular Permeability in Lung Adenocarcinoma

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yeh, Hsuan Heng ^a,b   Chang, Wen Tsan ^a   Lu, Kuang Chu ^a   Lai, Wu Wei ^b   Liu, Hsiao Sheng ^a,c   Su, Wu Chou ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; JANUS KINASE 2; MESSENGER RNA; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; STAT3 PROTEIN; THROMBOPLASTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; BLOOD VESSEL PERMEABILITY; CANCER CELL; CANCER INHIBITION; CELL ADHESION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE SILENCING; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; LUNG ADENOCARCINOMA; LUNG METASTASIS; MALIGNANT ASCITES; MALIGNANT PLEURA EFFUSION; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; UPREGULATION;

ADENOCARCINOMA; ANIMALS; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; DNA PRIMERS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE KNOCKDOWN TECHNIQUES; INTERLEUKIN-6; JANUS KINASE 2; LUCIFERASES; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM METASTASIS; PLEURAL EFFUSION, MALIGNANT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; STAT3 TRANSCRIPTION FACTOR; THROMBOPLASTIN; UP-REGULATION;

EID: 84884688721     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075287     Document Type: Article

References (47)

1. Anderson CB, Philpott GW, Ferguson TB, (1974) The treatment of malignant pleural effusions. Cancer 33: 916-922. doi:10.1002/1097-0142(197404)33:4. PubMed: 4362107.
2. Memon A, Zawadzki ZA, (1981) Malignant effusions: diagnostic evaluation and therapeutic strategy. Curr Probl Cancer 5: 1-30. doi:10.1016/0146-2806(81)90020-7. PubMed: 6263549.
3. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, et al. (2001) Management of malignant pleural effusions. Eur Respir J 18: 402-419. doi:10.1183/09031936.01.00225601. PubMed: 11529302.
4. Camerer E, Kolstø AB, Prydz H, (1996) Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 81: 1-41. doi:10.1016/0049-3848(95)00209-X. PubMed: 8747518.
5. Belting M, Ahamed J, Ruf W, (2005) Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arterioscler Thromb Vasc Biol 25: 1545-1550. doi:10.1161/01.ATV.0000171155.05809.bf. PubMed: 15905465.
6. Versteeg HH, Ruf W, (2006) Emerging insights in tissue factor-dependent signaling events. Semin Thromb Hemost 32: 24-32. doi:10.1055/s-2006-933337. PubMed: 16479459.
7. Abe K, Shoji M, Chen J, Bierhaus A, Danave I, et al. (1999) Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci U S A 96: 8663-8668. doi:10.1073/pnas.96.15.8663. PubMed: 10411932.
8. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, et al. (2004) Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med 10: 502-509. doi:10.1038/nm1037. PubMed: 15098027.
9. Rickles FR, Patierno S, Fernandez PM, (2003) Tissue factor, thrombin, and cancer. Chest 124: 58S-68S. doi:10.1378/chest.124.3_suppl.58S. PubMed: 12970125.
10. Shigemori C, Wada H, Matsumoto K, Shiku H, Nakamura S, et al. (1998) Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemost 80: 894-898. PubMed: 9869156.
11. Ueno T, Toi M, Koike M, Nakamura S, Tominaga T, (2000) Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration. Br J Cancer 83: 164-170. doi:10.1054/bjoc.2000.1272. PubMed: 10901365.
12. Regina S, Valentin JB, Lachot S, Lemarié E, Rollin J, et al. (2009) Increased tissue factor expression is associated with reduced survival in non-small cell lung cancer and with mutations of TP53 and PTEN. Clin Chem 55: 1834-1842. doi:10.1373/clinchem.2009.123695. PubMed: 19661141.
13. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A, (1995) Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci U S A 92: 8205-8209. doi:10.1073/pnas.92.18.8205. PubMed: 7667269.
14. Mueller BM, Ruf W, (1998) Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest 101: 1372-1378. doi:10.1172/JCI930. PubMed: 9525979.
15. Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, et al. (2008) Inhibition of tissue factor signaling suppresses tumor growth. Blood 111: 190-199. doi:10.1182/blood-2007-07-101048. PubMed: 17901245.
16. Yano S, Shinohara H, Herbst RS, Kuniyasu H, Bucana CD, et al. (2000) Production of experimental malignant pleural effusions is dependent on invasion of the pleura and expression of vascular endothelial growth factor/vascular permeability factor by human lung cancer cells. Am J Pathol 157: 1893-1903. doi:10.1016/S0002-9440(10)64828-6. PubMed: 11106562.
17. Gieseler F, Lühr I, Kunze T, Mundhenke C, Maass N, et al. (2007) Activated coagulation factors in human malignant effusions and their contribution to cancer cell metastasis and therapy. Thromb Haemost 97: 1023-1030. PubMed: 17549306.
18. Alexandrakis MG, Coulocheri SA, Bouros D, Mandalaki K, Karkavitsas N, et al. (2000) Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Oncol Rep 7: 1327-1332. PubMed: 11032938.
19. Hsu IL, Su WC, Yan JJ, Chang JM, Lai WW, (2009) Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control. Lung Cancer 65: 371-376. doi:10.1016/j.lungcan.2008.12.007. PubMed: 19157636.
20. Stathopoulos GT, Kollintza A, Moschos C, Psallidas I, Sherrill TP, et al. (2007) Tumor necrosis factor-alpha promotes malignant pleural effusion. Cancer Res 67: 9825-9834. doi:10.1158/0008-5472.CAN-07-1064. PubMed: 17942913.
21. Yeh HH, Lai WW, Chen HH, Liu HS, Su WC, (2006) Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene 25: 4300-4309. doi:10.1038/sj.onc.1209464. PubMed: 16518408.
22. Moschos C, Psallidas I, Kollintza A, Karabela S, Papapetropoulos A, et al. (2009) The angiopoietin/Tie2 axis mediates malignant pleural effusion formation. Neoplasia 11: 298-304. PubMed: 19242611.
23. Stathopoulos GT, Psallidas I, Moustaki A, Moschos C, Kollintza A, et al. (2008) A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion. J Natl Cancer Inst 100: 1464-1476. doi:10.1093/jnci/djn325. PubMed: 18840818.
24. Stathopoulos GT, Zhu Z, Everhart MB, Kalomenidis I, Lawson WE, et al. (2006) Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion. Am J Respir Cell Mol Biol 34: 142-150. doi:10.1165/rcmb.2005-0130OC. PubMed: 16210694.
25. Liu Y, Jiang P, Capkova K, Xue D, Ye L, et al. (2011) Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy. Cancer Res 71: 6492-6502. doi:10.1158/0008-5472.CAN-11-1145. PubMed: 21880589.
26. Friedl J, Puhlmann M, Bartlett DL, Libutti SK, Turner EN, et al. (2002) Induction of permeability across endothelial cell monolayers by tumor necrosis factor (TNF) occurs via a tissue factor-dependent mechanism: relationship between the procoagulant and permeability effects of TNF. Blood 100: 1334-1339. PubMed: 12149215.
27. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, et al. (1999) Stat3 as an oncogene. Cell 98: 295-303. doi:10.1016/S0092-8674(00)81959-5. PubMed: 10458605.
28. Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, et al. (1996) A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15: 3651-3658. PubMed: 8670868.
29. Wang X, Wang M, Amarzguioui M, Liu F, Fodstad O, et al. (2004) Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice. Int J Cancer 112: 994-1002. doi:10.1002/ijc.20527. PubMed: 15386437.
30. Mackman N, Fowler BJ, Edgington TS, Morrissey JH, (1990) Functional analysis of the human tissue factor promoter and induction by serum. Proc Natl Acad Sci U S A 87: 2254-2258. doi:10.1073/pnas.87.6.2254. PubMed: 2315317.
31. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, et al. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17: 353-360. doi:10.1165/ajrcmb.17.3.2837. PubMed: 9308922.
32. Yeh HH, Wu CH, Giri R, Kato K, Kohno K, et al. (2008) Oncogenic Ras-induced morphologic change is through MEK/ERK signaling pathway to downregulate Stat3 at a posttranslational level in NIH3T3 cells. Neoplasia 10: 52-60. doi:10.1593/neo.07691. PubMed: 18231638.
33. Buettner R, Mora LB, Jove R, (2002) Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8: 945-954. PubMed: 11948098.
34. Im JH, Fu W, Wang H, Bhatia SK, Hammer DA, et al. (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64: 8613-8619. doi:10.1158/0008-5472.CAN-04-2078. PubMed: 15574768.
35. Dorfleutner A, Hintermann E, Tarui T, Takada Y, Ruf W, (2004) Cross-talk of integrin alpha3beta1 and tissue factor in cell migration. Mol Cell Biol 15: 4416-4425. doi:10.1091/mbc.E03-09-0640. PubMed: 15254262.
36. Sawada M, Miyake S, Ohdama S, Matsubara O, Masuda S, et al. (1999) Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. Br J Cancer 79: 472-477. doi:10.1038/sj.bjc.6690073. PubMed: 10027315.
37. Kasthuri RS, Taubman MB, Mackman N, (2009) Role of tissue factor in cancer. J Clin Oncol 27: 4834-4838. doi:10.1200/JCO.2009.22.6324. PubMed: 19738116.
38. Amarzguioui M, Peng Q, Wiiger MT, Vasovic V, Babaie E, et al. (2006) Ex vivo and in vivo delivery of anti-tissue factor short interfering RNA inhibits mouse pulmonary metastasis of B16 melanoma cells. Clin Cancer Res 12: 4055-4061. doi:10.1158/1078-0432.CCR-05-2482. PubMed: 16818705.
39. Gil-Bernabé AM, Ferjancic S, Tlalka M, Zhao L, Allen PD, et al. (2012) Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice. Blood 119: 3164-3175. doi:10.1182/blood-2011-08-376426. PubMed: 22327225.
40. Zhang Y, Deng Y, Luther T, Müller M, Ziegler R, et al. (1994) Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94: 1320-1327. doi:10.1172/JCI117451. PubMed: 7521887.
41. Milsom CC, Yu JL, Mackman N, Micallef J, Anderson GM, et al. (2008) Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis. Cancer Res 68: 10068-10076. doi:10.1158/0008-5472.CAN-08-2067. PubMed: 19074872.
42. Provençal M, Labbé D, Veitch R, Boivin D, Rivard GE, et al. (2009) c-Met activation in medulloblastoma induces tissue factor expression and activity: effects on cell migration. Carcinogenesis 30: 1089-1096. doi:10.1093/carcin/bgp085. PubMed: 19359592.
43. Yu JL, May L, Lhotak V, Shahrzad S, Shirasawa S, et al. (2005) Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis. Blood 105: 1734-1741. doi:10.1182/blood-2004-05-2042. PubMed: 15494427.
44. Rong Y, Belozerov VE, Tucker-Burden C, Chen G, Durden DL, et al. (2009) Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. Cancer Res 69: 2540-2549. doi:10.1158/0008-5472.CAN-08-1547. PubMed: 19276385.
45. Mackman N, (1995) Regulation of the tissue factor gene. FASEB J 9: 883-889. PubMed: 7615158.
46. Rong Y, Hu F, Huang R, Mackman N, Horowitz JM, et al. (2006) Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res 66: 7067-7074. doi:10.1158/0008-5472.CAN-06-0346. PubMed: 16849552.
47. Krikun G, Schatz F, Mackman N, Guller S, Demopoulos R, et al. (2000) Regulation of tissue factor gene expression in human endometrium by transcription factors Sp1 and Sp3. Mol Endocrinol 14: 393-400. doi:10.1210/me.14.3.393. PubMed: 10707957.